A review of pharmacotherapeutics for prosthetic dentistry: Part I

Journal of Prosthetic Dentistry

Volumn 77, Issue 3, 1997, Pages 285-292

  Felpel, Leslie P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRINGENT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; HEMOSTATIC AGENT; LOCAL ANESTHETIC AGENT; NEW DRUG; NON PRESCRIPTION DRUG; VASOCONSTRICTOR AGENT;

DRUG EFFECT; DRUG THERAPY; DRUG UTILIZATION; HUMAN; MOUTH HYGIENE; REVIEW; SALIVATION; TOOTH PROSTHESIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ASTRINGENTS; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; DRUG THERAPY; DRUG UTILIZATION; DRUGS, INVESTIGATIONAL; DRUGS, NON-PRESCRIPTION; HEMOSTATICS; HUMANS; MOUTHWASHES; PARASYMPATHOMIMETICS; PROSTHODONTICS; SALIVATION; VASOCONSTRICTOR AGENTS;

EID: 0031093758     PISSN: 00223913     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3913(97)70186-0     Document Type: Article

References (29)

1. Blackmore J.W. Local anesthetics and sulfite sensitivity. J Can Dent Assoc 54 (1988) 349-352
2. Butterworth J.I., and Strichartz G.R. Molecular mechanisms of local anesthesia: a review. Anesthesiology 72 (1990) 711-734
3. Adriani J., and Zepernick R. Clinical effectiveness of drugs used for topical anesthesia. JAMA 188 (1964) 711-716
4. Adriani J., and Campbell D. Fatalities following topical application of local anesthetics to mucous membranes. JAMA 162 (1956) 1527-1530
5. Dailey R.H. Fatality secondary to misuse of TAC solution. Ann Emerg Med 17 (1988) 159-160
6. Rodriguez L.F., Smolik L.M., and Zbehlik A.J. Benzocaine-induced methemoglobinemia: report of a severe reaction and review of the literature. Ann Pharmacother 28 (1994) 643-649
7. Vessely M.B., and Zitsch III R.P. Topical anesthetic-induced methemoglobinemia: a case report and review of the literature. Otolarygol Head Neck Surg 108 (1993) 763-767
8. Kreutz R.W., and Kinni M.C. Life-threatening toxic methemoglobinemia induced by prilocaine. Oral Health 75 (1985) 19-20
9. Block A., and Covino B.G. Effect of local anesthetic agents on cardiac conduction and contractility. Reg Anesth 6 (1981) 55-61
10. Smudski J.W., Sprecher R.L., and Elliott H.W. Convulsive interactions of promethazine, meperidine and lidocaine. Arch Oral Biol 9 (1964) 595-600
11. Eidelberg E., Neer H.M., and Miller M.K. Anticonvulsant properties of some benzodiazepine derivatives. Neurology 15 (1965) 223-230
12. Kopacz D.J., Carpenter R.L., and Mackey D.C. Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology 71 (1990) 69-74
13. Kaplan E.L. Cardiovascular disease in dental practice (1986), American Heart Association, Dallas 1-31
14. Yagiela J.A. Vasoconstrictor agents for local anesthesia. Anesth Prog 42 (1995) 116-120
15. Yagiela J.A., Duffin S.R., and Hunt L.M. Drug interactions and vasoconstrictors used in local anesthetic solutions. Oral Surg Oral Med Oral Pathol 59 (1985) 565-571
16. Hargreaves K., Jackson D., Geier H., and Garry M. Evaluation of the efficacy of a bioerodible bupivacaine polymer during CFA inflammation [abstract]. J Dent Res 72 (1993) 186
17. Hersh E.V., Maniar M., Green M., and Cooper S.A. Anesthetic activity of the lipospheres bupivacaine delivery system in the rat. Anesth Prog 39 (1992) 197-200
18. Cowan F.F. Dental pharmacology. 2nd ed (1992), Lea & Febiger, Philadelphia 272-273
19. Ciancio S.G., and Bourgault P.C. Clinical pharmacology for dental professionals. 3rd ed (1989), Year Book Medical Publishers, Chicago 316
20. Neidle E.A., and Yagiela J.A. Pharmacology and therapeutics for dentistry. 3rd ed (1989), CV Mosby, St Louis 438
21. Woycheshin F.F. An evaluation of the drugs used for gingival retraction. J Prosthet Dent 14 (1964) 769-776
22. Sreebny L.M. A reference guide to drugs and dry mouth. Gerdontology 5 (1986) 75-99
23. Tapper-Jones L., Aldred M., and Walker D.M. Prevalence and intraoral distribution of Candida albicans and Sjögren's syndrome. J Clin Pathol 33 (1980) 282-287
24. Fox P.C., van der Ven P.F., Baum B.J., and Mandel I.D. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 61 (1986) 243-248
25. Johnson J.T., Ferretti G.A., Nethery W.J., Valdez I.H., Fox P.C., Ng D., et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329 (1993) 390-395
26. Mandel I.D., Katz R., Zengo A., Kutscher A.H., Greenberg R.A., Katz S., et al. The effect of pharmacologic agents on salivary secretion and composition in man. I. Pilocarpine, atropine and anticholinesterases. J Oral Therap Pharmacol 4 (1967) 192-199
27. Levine M.J. Development of artificial salivas. Crit Rev Oral Biol Med 4 (1993) 279-286
28. Herod E.L. The use of milk as a saliva substitute. J Public Health Dent 54 (1994) 184-189
29. Marquis R.E. Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol 41 (1995) 955-964